Predictive value of 18 F-FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non-small cell lung cancer.
Qian ZhangXiuli TaoPei YuanZewei ZhangJianming YingLei GuoNing LiShuhang WangJing LiYing LiuWei GuoShijun ZhaoNing WuPublished in: Cancer medicine (2023)
MPs and STMs can predict the TMB level for patients with ADC, and may serve as potential substitutes for TMB with increased value and easy implementation in guiding immunotherapy through noninvasive methods.